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a b s t r a c t
Neuroticism as a personality trait represents a heritable risk
for psychiatric disorders. The polygenic risk score for neuroticism (N-PRS) is used to study genetic vulnerability to
neuroticism. The current data present the association of the
genetic risk for neuroticism to neural reward-punishment
processing using functional magnetic resonance imaging.
N-PRS was computed based on the individual’s genotype information and a genome-wide association study on the UK
Biobank data. While individuals performed a monetary incentive delay task, their neural activations for upcoming incentives (reward: gain, punishment: loss) were measured
in blood oxygen level dependent (BOLD) signals during the
delay phase. Multivariate ANCOVAs were used to analyze
BOLD signals for ﬁnding the association between N-PRS and
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reward-punishment processing by the incentive valence (Related research article: H. Park, K.L. Forthman, R. Kuplicki,
T.A. Victor, Tulsa 10 0 0 Investigators, H.W. Yeh, W.K. Thompson, M.P. Paulus, Polygenic risk for neuroticism modulates response to gains and losses in the amygdala and
caudate: evidence from a clinical cohort. J. Affect. Disord. 293 (2021) 124–132. https://doi.org/10.1016/j.jad.2021.
06.016). These data can be used as reference data for future
studies examining the role of the genetic propensity for personality traits in the context of psychiatric disorders.
© 2022 The Author(s). Published by Elsevier Inc.
This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/)

Speciﬁcation Table
Subject
Speciﬁc subject area
Type of data
How data were acquired

Data format
Parameters for data collection

Description of data collection

Data source location

Data accessibility

Related research article

Biological Sciences
Health and Medical Sciences
Neuroscience: Biological Psychiatry
Psychiatry and Mental Health
Table
The Magnetic Resonance Imaging (MRI) data were collected using the GE
MR750 3T scanner with 8 RF coils for both anatomical and functional scans.
Self-report measurements were electronically administered on Apple iPad
using a secure web-based application for the electronic collection of research
and clinical trial data (www.project-redcap.org).
Raw
Derived
The dataset is a part of the Tulsa 10 0 0 project data. Anatomical images
(T1-weighted 3D high resolution) were acquired in the MP-RAGE pulse
sequence with scanning parameters of FOV 240 × 192 mm,
TR/TE = 5/2.012 ms, and 186 axial slices. Functional images (T2∗ -weighted
echo-planar images) were collected in 562 axial volumes (39 slices, 2.9 mm
thick, 1.8753 voxels) with the parameters of ﬂip angle 78°, FOV
240 × 240 mm, and TR/TE = 20 0 0/27 ms.
N-PRS was computed based on the individual’s genotype information and
genome-wide association study (GWAS) summary statistics. MRI data were
preprocessed and analysed with AFNI (Analysis of Functional NeuroImages
software suite). PHQ-9 scores were collected through self-report.
Institution: Laureate Institute for Brain Research
City/Town/Region: Tulsa, Oklahoma
Country: U.S.A.
Repository name: Mendeley Data
Data identiﬁcation number: N/A
Direct URL to data:
PARK, HEEKYEONG (2021), “N-PRS and Reward Processing_469”, Mendeley
Data, V1, doi: 10.17632/n4534vcjkh.1
http://dx.doi.org/10.17632/n4534vcjkh.1
Co-submission:
H. Park, K.L. Forthman, R. Kuplicki, T.A. Victor, Tulsa 10 0 0 Investigators, H.W.
Yeh, W.K. Thompson, M.P. Paulus, Polygenic risk for neuroticism modulates
response to gains and losses in amygdala and caudate: evidence from a clinical
cohort, J. Affect. Disord. 293 (2021) 124–132.
https://doi.org/10.1016/j.jad.2021.06.016
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Value of the Data
• The data can be used to replicate the results of [1].
• The data contribute to understanding the genetic impact of neuroticism in increasing vulnerability for psychiatric disorders in public health.
• The data can be used for future studies examining the relationship between genetic risks of
personality traits and functional neural markers for psychiatric disorders.

1. Data Description
This paper includes the data regarding the association between polygenic risk scores for neuroticism (N-PRS) and reward-punishment processing on the Monetary Incentive Delay task (MID)
from a functional MRI experiment [2]. The present dataset is based on 469 individuals’ data on
N-PRS and BOLD signals by the incentive during the MID task. Table 1 displays BOLD signals
showing the relationship between N-PRS and neural activity for reward-punishment processing
after covarying out the participant’s psychiatric diagnosis (depression, anxiety, substance use,
eating disorders, as well as healthy control) in the statistical analysis. Table 2 presents BOLD
signal changes associated with N-PRS but not with depression severity on the Patient Health
Questionnaire (PHQ-9) in individuals with major depression disorders [3]. For both tables, the
ﬁrst column denotes an arbitrary number assigned to each participant. In the tables, the abbreviation ‘A’ represents the amygdala, while ‘I’ and ‘P’ represent the insula and the precuneus,
respectively. In Table 2, ‘C’ represents the tail of the caudate.

2. Experimental Design, Materials and Methods
2.1. Participants
Participants were drawn from the ﬁrst 500 individuals (T500) in the Tulsa 10 0 0 project, a
naturalistic study following 10 0 0 individuals with mood, anxiety, substance use, and/or eating
disorders as well as healthy volunteers [4]. The eligibility criteria for the clinical population
were (1) Patient Health Questionnaire (PHQ-9) ≥ 10 [3]; (2) Overall Anxiety Severity and Impairment Scale (OASIS) ≥ 8 [5]; (3) Drug Abuse Screening Test (DAST-10) score ≥ 3 [6]; and/or
(4) Eating Disorder Screen (SCOFF) score ≥ 2 [7]. Healthy volunteers screened negative for the
above scales. Exclusion criteria included: positive results on a drug screening test; lifetime bipolar, schizophrenia spectrum, antisocial personality, or obsessive-compulsive disorders; active suicidal ideation; moderate to severe traumatic brain injury; severe or unstable medical conditions;
change in psychiatric medication dose within the last 6 weeks; and MRI contraindications. All
procedures were conducted following the study protocol approved by the Western Institutional
Review Board. Prior to the study, all participants gave informed consent, and they were remunerated for their participation. Participants who had excessive head motions or incomplete data
were excluded, resulting in 469 participants.

2.2. Polygenic risk score for neuroticism (N-PRS)
Participants’ blood samples were genotyped using Illumina Inﬁnium Global Screening Array24 (v.2.0) BeadChip arrays by RUDCR Inﬁnite Biologics. The genotyped data then underwent
three rounds of quality control. In the ﬁrst round of quality control, we checked for mismatches in the strand, ID names, position, alleles, and ref/alt assignments. We used the McCarthy Group Tool (HRC or 10 0 0G Imputation preparation and checking, v.4.2.11) to compare
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genotypes to the Haplotype Reference Consortium (HRC) release 1.1 reference panel. The McCarthy Group Tool outputs the following corrections: SNPs to exclude, name corrections, strand
ﬂips, and allele ﬂips. The recommended corrections were applied using the software PLINK (v.1.9,
https://www.cog-genomics.org/plink2; v.2.0, https://www.cog-genomics.org/plink/2.0). The second round of quality control applied several exclusion criteria for SNPs, including (1) call rates
lower than 2%, (2) duplicated SNPs, and (3) violation of Hardy-Weinberg equilibrium. The third
round of quality control applied exclusion criteria for participants in the sample, including (1)
missingness greater than 2% and (2) close genetic relationship with any participant (πˆ > 0.2)
within the sample. Both the second and third rounds of quality control were also conducted with
PLINK. Genotype Imputation was done via the Michigan Imputation Server Pipeline using Minimac4, version 1.2.4 [8], with the options, (1) Reference Panel – HRC r1.1 2016 (GRCh37/hg19),
(2) Array Build – GRCh37/hg19, (3) rsq Filter – off, (4) Phasing – Eagle v2.4 (phased output), (5)
Population – Other/Mixed, (6) Mode – Quality Control & Imputation, (7) AES 256 encryption –
unchecked. Genome information was imputed from 569,641 to 40,359,612 SNPs [8].
A genome-wide association study (GWAS) for neuroticism was taken from the Atlas of GWAS
Summary Statistics (https://atlas.ctglab.nl). The selected GWAS was performed by the Center for
Neurogenomics and Cognitive Research (CNCR) Complex Trait Genetics Laboratory (CTG Lab) on
data from the UK Biobank, release 2. The GWAS summary ﬁle was downloaded from the CTG
Lab website (https://atlas.ctglab.nl/traitDB/3990#:∼:text=https%3A//ctg.cncr.nl/documents/p1651/
sumstats_neuro_sum_ctg_format.txt.gz). The GWAS describes the strength and signiﬁcance of the
association of 10,846,943 SNPs with neuroticism measured on a 12-item sum scale from 380,060
participants [9]. N-PRS was computed using PRSice-2 [10]. We accounted for linkage disequilibrium (LD) by clumping in PRSice using standard parameters (250 kilobases, r2 = 0.1, p = 1),
resulting in 144,443 SNPs. Principal component analysis (PCA) was used to quantify population
stratiﬁcation (i.e., genetic ancestry) with 10 components. PCA was performed using FlashPCA2
[11]. The GWAS summary included p-values for the relationship between each SNP and neuroticism. To reduce noise, a p-value threshold was used to determine which SNPs to include in
the calculation of the PRS. To choose the optimal p-value threshold, 14 p-value thresholds were
selected (5×10−8 , 5×10−7 , 5×10−6 , 5×10−5 , 5×10−4 , 0.0 01, 0.0 05, 0.05, 0.1, 0.2, 0.3, 0.4, 0.5, &
1), and a PRS was created for the T500 cohort at each threshold. Each PRS was then compared
to the T500 participant neuroticism score from the Big Five Inventory. For this comparison, two
linear models were created: the ﬁrst predicted neuroticism score using the PRS and the 10 principal components of population stratiﬁcation, while the second predicted neuroticism score using only the principal components. The variance explained was quantiﬁed with the R2 of the
second model subtracted from the R2 of the ﬁrst model. The p-value thresholds from 0.05 to 1
explained the variance greater than 0.025. Because there is no a-priori method to determine
the best threshold, and because the p-value thresholds between 0.05 and 1 shared approximately equivalent ﬁt to the phenotype, we chose the most stringent threshold of 0.05 among the
p-value thresholds that explained greater than 0.025 of the variance. For this study, N-PRS was
standardized across participants with a mean of zero and a standard deviation of 1.

2.3. fMRI experiment
The MID task was used to examine neural processes associated with reward and punishment.
The study design consisted of 2 levels of valence (gain, loss) and 3 levels of magnitude of the
incentive (high, low, no), yielding 6 conditions, high-gain/high-loss (+$5/-$5), low-gain/low-loss
(+$1/-$1), and no-gain/no-loss (+$0/-$0), with 15 trials per condition. A trial began with a task
cue (an object) for 2 s indicating the valence (circle: gain, square: loss) and magnitude (top:
$5, middle: $1, bottom: $0) of the incentive for the trial by the shape of the task cue and the
location of a line in the cue, respectively. After a varied delay between 2.25 s and 3 s, a target of
the trial (a triangle) was presented, prompting participants to press a button to gain reward or
to avoid loss as early as they could. Participants received practice trials out of the scanner before
the scan session. The mean response time of each participant collected from practice trials was
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Fig. 1. The workﬂow diagram of the study.

used for adjusting the individualized target duration for approximately 66% of success on button
press. After the target, the outcome with the amount of earned/lost money was presented for
2 s as feedback. The study lasted about 19 min in the scanner.
Both T1-weighted 3D high-resolution anatomical images (MP-RAGE pulse sequence, FOV
240 × 192 mm, TR/TE = 5/2.012 ms, 186 axial slices) and T2∗ -weighted echo-planar images (ﬂip
angle 78°, FOV 240 × 240 mm, TR/TE = 20 0 0/27 ms, axial plane, 39 slices/volume, 2.9 mm thick,
1.875 × 1.875 mm voxels) were collected using two GE MR750 3T scanners equipped with 8 RF
channel phased array coils at the Laureate Institute for Brain Research. fMRI data were acquired
in two runs of 281 volumes while participants performed the MID task in the scanner.

2.4. fMRI data preprocessing and analysis
The Analysis of Functional NeuroImages software suite (AFNI, https://afni.nimh.nih.gov/) was
used for preprocessing and analyzing imaging data. The ﬁrst 3 volumes were discarded to avoid
magnetic saturation effects. fMRI data were despiked, slice-time corrected to the ﬁrst slice, coregistered to a T1-weighted anatomical image, and motion-corrected (ENORM > 0.3). Functional
data were also normalized to the MNI space with resampling of isotropic 2 mm voxels and
smoothed with an isotropic 4 mm FWHM Gaussian kernel. For analysis, 6 events were modeled
for anticipatory reward-punishment processing (±$5, ±$1, ±$0) on a subject level. To capture
motivational valence processing for an upcoming event, only anticipatory neural activity during
the delay phase was included in the analysis. The BOLD response to an incentive cue was convolved with a 4-s boxcar function from the onset of the cue. All other events were considered as
no-interest events including 6 motion parameters and the ﬁrst 4 polynomial terms. The contrasts
of incentive valence for gain (+$5 > +$0) and loss (−$5 > −$0) were constructed as the main
events-of-interest. The $1 conditions were not used for the analysis. A multivariate ANCOVA
model (3dMVM: valence (2) ∗ N-PRS) was constructed to investigate the association between
N-PRS and anticipatory reward-punishment processing in the brain with covariates of age, sex,
and race, at the group level. The effect of PRS for neuroticism was examined for each valence
separately and collapsed over the valence for estimating the main effect. The contrast showing
the difference between gain versus loss by PRS was used for an interaction effect. A voxel-wise
threshold of p < .001 was used for this study in conjunction with a cluster-extent threshold of
α < .05 (k > 43) based on the estimated ACF parameters of the group level error terms using
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3dFWHMx and 3dClustSim. Signiﬁcant clusters were further probed with beta coeﬃcients in the
clusters for follow-up comparisons. Self-reported PHQ-9 scale scores were used for estimating
the severity of depressive symptoms Fig. 1. shows the diagram depicting the workﬂow of the
study method.
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